SCHEMBL1032891

SCHEMBL1032891

Cc1cc(C(=O)CCc2sc3ccc(C(F)(F)F)cc3c2C)ccc1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.37
ESRRG P62508 1/20 0.36
TBXAS1 P24557 1/20 0.36
DYRK1A Q13627 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
FFAR4 Q5NUL3 1/20 0.35
MAPT P10636 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MMP1 P03956 1/20 0.33
CYP1A2 P05177 1/20 0.33
FRK P42685 1/20 0.33
CAMK2B Q13554 1/20 0.33
CAMK2G Q13555 1/20 0.33
CAMK2D Q13557 1/20 0.33
AKT1 P31749 1/20 0.33
GPR52 Q9Y2T5 1/20 0.33
CTNNB1 P35222 1/20 0.33
WNT3A P56704 1/20 0.33
ESR1 P03372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1034982 0.92 BCL2L1 (0.37) BCL2L1ESRRGTBXAS1DYRK1ADYRK1B
SCHEMBL27829362 0.84 KCNK3 (0.41) TBXAS1MAPTMEN1KMT2ACYP1A2
SCHEMBL1035193 0.83 PPARD (0.47)
SCHEMBL1030631 0.83 PPARD (0.44)
SCHEMBL1035525 0.82 CYP1A2 (0.45) DYRK1ADYRK1BMAPTMEN1KMT2A
SCHEMBL1035053 0.82 BCL2L1 (0.35) BCL2L1ESRRGDYRK1ADYRK1BFFAR4
SCHEMBL1034264 0.81 ESR1 (0.43) FFAR4ESR1
SCHEMBL1030579 0.80 FBP1 (0.38)
SCHEMBL1082173 0.80 PPARD (0.46) TBXAS1FFAR4
SCHEMBL1035195 0.78 PPARA (0.40) TBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3424917-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2019-01-09 EP disclosed
EP-2277874-B1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO (JP) 2018-06-27 EP disclosed
US-8648208-B2 Activating agent for peroxisome proliferator activated receptor NIPPON CHEMIPHAR CO. LTD. (JP) 2014-02-11 US disclosed
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO. LTD. (JP) 2011-04-28 US disclosed
EP-2277874-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2011-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR PPARA, PPARG, PPARD BCL2L1 765/4885ESRRG 111/4885TBXAS1 439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.